ClearBridge Investments
VRTX icon

ClearBridge Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$680M Sell
1,527,864
-151,307
-9% -$67.4M 0.55% 44
2025
Q1
$814M Sell
1,679,171
-171,687
-9% -$83.2M 0.71% 28
2024
Q4
$745M Sell
1,850,858
-121,197
-6% -$48.8M 0.6% 40
2024
Q3
$917M Sell
1,972,055
-118,649
-6% -$55.2M 0.72% 31
2024
Q2
$980M Sell
2,090,704
-337,751
-14% -$158M 0.8% 23
2024
Q1
$1.02B Sell
2,428,455
-164,120
-6% -$68.6M 0.8% 18
2023
Q4
$1.05B Sell
2,592,575
-350,609
-12% -$143M 0.91% 14
2023
Q3
$1.02B Sell
2,943,184
-208,238
-7% -$72.4M 0.98% 12
2023
Q2
$1.11B Sell
3,151,422
-186,319
-6% -$65.6M 1% 14
2023
Q1
$1.05B Sell
3,337,741
-148,379
-4% -$46.7M 1% 14
2022
Q4
$1.01B Sell
3,486,120
-414,736
-11% -$120M 0.99% 14
2022
Q3
$1.13B Sell
3,900,856
-342,408
-8% -$99.1M 1.14% 12
2022
Q2
$1.2B Sell
4,243,264
-909,488
-18% -$256M 1.11% 12
2022
Q1
$1.34B Sell
5,152,752
-43,978
-0.8% -$11.5M 1.01% 16
2021
Q4
$1.14B Buy
5,196,730
+84,326
+2% +$18.5M 0.78% 23
2021
Q3
$927M Buy
5,112,404
+129,810
+3% +$23.5M 0.66% 32
2021
Q2
$1B Sell
4,982,594
-538,616
-10% -$109M 0.7% 28
2021
Q1
$1.19B Buy
5,521,210
+1,244,784
+29% +$267M 0.88% 21
2020
Q4
$1.01B Sell
4,276,426
-194,854
-4% -$46.1M 0.78% 25
2020
Q3
$1.22B Buy
4,471,280
+304,248
+7% +$82.8M 1.05% 18
2020
Q2
$1.21B Buy
4,167,032
+325,938
+8% +$94.6M 1.09% 17
2020
Q1
$914M Sell
3,841,094
-283,619
-7% -$67.5M 0.99% 19
2019
Q4
$905M Sell
4,124,713
-891,172
-18% -$196M 0.75% 30
2019
Q3
$850M Sell
5,015,885
-161,981
-3% -$27.4M 0.74% 31
2019
Q2
$950M Sell
5,177,866
-136,839
-3% -$25.1M 0.82% 30
2019
Q1
$978M Sell
5,314,705
-168,447
-3% -$31M 0.86% 27
2018
Q4
$909M Sell
5,483,152
-62,814
-1% -$10.4M 0.92% 21
2018
Q3
$1.07B Sell
5,545,966
-454,501
-8% -$87.6M 0.92% 19
2018
Q2
$1.02B Sell
6,000,467
-390,259
-6% -$66.3M 0.83% 23
2018
Q1
$1.04B Sell
6,390,726
-294,943
-4% -$48.1M 0.98% 18
2017
Q4
$1B Sell
6,685,669
-394,502
-6% -$59.1M 0.93% 19
2017
Q3
$1.08B Sell
7,080,171
-838,582
-11% -$127M 1.04% 15
2017
Q2
$1.02B Sell
7,918,753
-835,865
-10% -$108M 1% 14
2017
Q1
$957M Buy
8,754,618
+105,260
+1% +$11.5M 0.96% 16
2016
Q4
$637M Buy
8,649,358
+1,350,349
+19% +$99.5M 0.7% 29
2016
Q3
$637M Sell
7,299,009
-275,774
-4% -$24.1M 0.72% 31
2016
Q2
$652M Sell
7,574,783
-48,541
-0.6% -$4.18M 0.77% 25
2016
Q1
$606M Sell
7,623,324
-88,934
-1% -$7.07M 0.72% 29
2015
Q4
$970M Sell
7,712,258
-80,021
-1% -$10.1M 1.12% 13
2015
Q3
$811M Sell
7,792,279
-69,102
-0.9% -$7.2M 0.97% 15
2015
Q2
$971M Sell
7,861,381
-64,673
-0.8% -$7.99M 1.03% 13
2015
Q1
$935M Buy
7,926,054
+402,429
+5% +$47.5M 0.97% 15
2014
Q4
$894M Sell
7,523,625
-75,546
-1% -$8.97M 0.94% 14
2014
Q3
$853M Buy
7,599,171
+49,753
+0.7% +$5.59M 0.94% 16
2014
Q2
$715M Buy
7,549,418
+292,041
+4% +$27.7M 0.8% 23
2014
Q1
$513M Buy
7,257,377
+355,907
+5% +$25.2M 0.61% 38
2013
Q4
$513M Buy
6,901,470
+1,013,429
+17% +$75.3M 0.64% 38
2013
Q3
$446M Buy
5,888,041
+285,231
+5% +$21.6M 0.62% 36
2013
Q2
$449M Buy
+5,602,810
New +$449M 0.68% 33